{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-06-10&answer.answeringMemberPrinted=Baroness+Barran", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2019-06-10&answer.answeringMemberPrinted=Baroness+Barran", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-06-10&_metadata=all&answer.answeringMemberPrinted=Baroness+Barran", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-06-10&_page=0&answer.answeringMemberPrinted=Baroness+Barran", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-06-10&answer.answeringMemberPrinted=Baroness+Barran", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-06-10&answer.answeringMemberPrinted=Baroness+Barran", "items" : [{"_about" : "http://data.parliament.uk/resources/1130820", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1130820/answer", "answerText" : {"_value" : "

The General Medical Council\u2019s (GMC\u2019s) ethical guidance Good practice in prescribing and managing medicines and devices (2013)<\/em> sets out that with all prescriptions, it is expected that clinicians make sure that suitable arrangements are in place for monitoring, follow-up and review, taking account of the patients\u2019 needs and any risks arising from the medicines.<\/p>

A copy of the GMC guidance is attached.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4703", "label" : {"_value" : "Biography information for Baroness Barran"} } , "answeringMemberPrinted" : {"_value" : "Baroness Barran"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1130820/answer/attachment/1", "fileName" : {"_value" : "prescribing-guidance_pdf-59055247.pdf"} , "title" : "Prescribing_guidance"} , "dateOfAnswer" : {"_value" : "2019-06-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-24T15:16:33.257Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-06-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Opioids: Prescriptions"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have, if any, to ensure that individuals prescribed opioid medication for chronic pain have their prescriptions reviewed on an annual basis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4307", "label" : {"_value" : "Biography information for The Lord Bishop of Carlisle"} } , "tablingMemberPrinted" : [{"_value" : "The Lord Bishop of Carlisle"} ], "uin" : "HL16187"} , {"_about" : "http://data.parliament.uk/resources/1130838", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1130838/answer", "answerText" : {"_value" : "

It is unacceptable if patients are being put at risk by a service that deliberately places itself beyond the jurisdiction of United Kingdom regulators.<\/p>

The Department is working closely with the Care Quality Commission and relevant professional regulators to explore how it can close the loopholes that allow a small number of online organisations to operate without the necessary oversight.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4703", "label" : {"_value" : "Biography information for Baroness Barran"} } , "answeringMemberPrinted" : {"_value" : "Baroness Barran"} , "dateOfAnswer" : {"_value" : "2019-06-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-24T15:30:40.48Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-06-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Gender Dysphoria: Children"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what steps they intend to take to prevent the illegal supply of puberty-blocking drugs to British children and adolescents by Dr Helena Webberley, who was recently suspended from the Medical Register by the General Medical CouncilĀ and who is advertising services from Spain.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/621", "label" : {"_value" : "Biography information for Lord Moonie"} } , "tablingMemberPrinted" : [{"_value" : "Lord Moonie"} ], "uin" : "HL16205"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }